ARTICLE | Clinical News
BLU-285: Preliminary Ph I data
December 14, 2016 10:56 PM UTC
Preliminary data from 12 patients with advanced systemic mastocytosis in the dose-escalation portion of an open-label, U.S. and U.K. Phase I trial showed that once-daily doses of 30, 60 and 100 mg ora...
BCIQ Company Profiles